A highly selective ratiometric fluorescent probe for in vitro monitoring and cellular imaging of human carboxylesterase 1

Biosensors and Bioelectronics

Volumn 57, Issue , 2014, Pages 30-35

  Liu, Zhao Ming ^a   Feng, Lei ^b   Ge, Guang Bo ^a   Lv, Xia ^a   Hou, Jie ^c   Cao, Yun Feng ^a   Cui, Jing Nan ^b   Yang, Ling ^a  

^a DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^b DALIAN UNIVERSITY OF TECHNOLOGY   (China)

^c DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Cell imaging; Human carboxylesterase 1; Large emission shift; Ratiometric fluorescent probe

Indexed keywords

BIOASSAY; CELLS; CYTOLOGY; FLUORESCENCE; FLUORESCENCE SPECTROSCOPY; PH; RED SHIFT;

CARBOXYLESTERASES; CELL IMAGING; EMISSION SHIFTS; ENDOGENOUS COMPOUND; FLUORESCENCE SPECTRA; FLUORESCENT PROBES; RED-SHIFTED EMISSION; SPECTROSCOPIC PROBES;

PROBES;

2 (2 HYDROXY 3 METHOXYPHENYL) BENZOTHIAZOLE; CARBOXYLESTERASE; CARBOXYLESTERASE 1; ESTER; FLUORESCENT DYE; UNCLASSIFIED DRUG;

ARTICLE; BIOASSAY; CELL ASSAY; CELL MEMBRANE PERMEABILITY; CELL STRAIN HEPG2; CHEMICAL BOND; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME STABILITY; FLUORESCENCE SPECTROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; PH MEASUREMENT; PHENOTYPE; SIGNAL DETECTION;

CELL IMAGING; HUMAN CARBOXYLESTERASE 1; LARGE EMISSION SHIFT; RATIOMETRIC FLUORESCENT PROBE;

BENZOTHIAZOLES; BIOSENSING TECHNIQUES; CARBOXYLIC ESTER HYDROLASES; ENZYME ASSAYS; FLUORESCENT DYES; HEP G2 CELLS; HUMANS; MICROSCOPY, FLUORESCENCE; MICROSOMES, LIVER; OPTICAL IMAGING; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, FLUORESCENCE;

EID: 84896717593     PISSN: 09565663     EISSN: 18734235     Source Type: Journal    
DOI: 10.1016/j.bios.2014.01.049     Document Type: Article

References (49)

1. Bencharit S., Edwards C.C., Morton C.L., Howard-Williams E.L., Kuhn P., Potter P.M., Redinbo M.R. J. Mol. Biol. 2006, 363:201-214.
2. Brzezinski M.R., Spink B.J., Dean R.A., Berkman C.E., Cashman J.R., Bosron W.F. Drug Metab. Dispos. 1997, 25:1089-1096.
3. Choi J.Y., Kim G.H., Guo Z., Lee H.Y., Swamy K.M., Pai J., Shin S., Shin I., Yoon J. Biosens. Bioelectron. 2013, 49:438-441.
4. Crow J.A., Middleton B.L., Borazjani A., Hatfield M.J., Potter P.M., Ross M.K. Biochim. Biophys. Acta 2008, 1781:643-654.
5. Cui L., Zhong Y., Zhu W., Xu Y., Qian X. Chem. Commun. 2010, 46:7121-7123.
6. Demchenko A.P., Callis P.R. Advanced Fluorescence Reporters in Chemistry and Biology I: Fundamentals and Molecular Design. Springer Ser Fluoresc 2010, 8:3-24.
7. Friedrichsen M., Poulsen P., Wojtaszewski J., Hansen P.R., Vaag A., Rasmussen H.B. PLoS One 2013, 8:e56861.
8. Giacobini E. Cholinesterases: Neurochem. Res. 2003, 28:515-522.
9. Hagihara K., Kazui M., Kurihara A., Yoshiike M., Honda K., Okazaki O., Farid N.A., Ikeda T. Drug Metab. Dispos. 2009, 37:2145-2152.
10. Hakamata W., Machida A., Oku T., Nishio T. Bioorg. Med. Chem. Lett. 2011, 21:3206-3209.
11. Harrison E.H. Annu. Rev. Nutr. 1998, 18:259-276.
12. Hatfield M.J., Potter P.M. Expert Opin. Ther.Ther. Pat. 2011, 21:1159-1171.
13. Hatfield M.J., Tsurkan L.G., Hyatt J.L., Edwards C.C., Lemoff A., Jeffries C., Yan B., Potter P.M. J. Nat. Prod. 2013, 76:36-44.
14. Igarashi M., Osuga J., Uozaki H., Sekiya M., Nagashima S., Takahashi M., Takase S., Takanashi M., Li Y., Ohta K., Kumagai M., Nishi M., Hosokawa M., Fledelius C., Jacobsen P., Yagyu H., Fukayama M., Nagai R., Kadowaki T., Ohashi K., Ishibashi S. Circ. Res. 2010, 107:1387-1395.
15. Kim Y., Choi Y., Weissleder R., Tung C.H. Chem. Lett. 2007, 17:5054-5057.
16. Li X., Gao X., Shi W., Ma H. Chem. Rev. 2014, 114:590-659.
17. Liu R., Tam T.W., Mao J., Saleem A., Krantis A., Arnason J.T., Foster B.C. J. Pharm. Pharm. Sci. 2010, 13:43-55.
18. Na K., Lee E.Y., Lee H.J., Kim K.Y., Lee H., Jeong S.K., Jeong A.S., Cho S.Y., Kim S.A., Song S.Y., Kim K.S., Cho S.W., Kim H., Paik Y.K. Proteomics 2009, 9:3989-3999.
19. Nemoda Z., Angyal N., Tarnok Z., Gadoros J., Sasvari-Szekely M. Neuropharmacology 2009, 57:731-733.
20. Quinney S.K., Sanghani S.P., Davis W.I., Hurley T.D., Sun Z., Murry D.J., Bosron W.F. J. Pharmacol. Exp. Ther. 2005, 313:1011-1016.
21. Quiroga A.D., Li L., Trotzmuller M., Nelson R., Proctor S.D., Kofeler H., Lehner R. Hepatology 2012, 56:2188-2198.
22. Redinbo M.R., Bencharit S., Potter P.M. Biochem. Soc. Trans. 2003, 31:620-624.
23. Redinbo M.R., Potter P.M. Drug Discov. Today 2005, 10:313-325.
24. Rhoades J.A., Peterson Y.K., Zhu H.J., Appel D.I., Peloquin C.A., Markowitz J.S. Pharm. Res. 2012, 29:972-982.
25. Ross M.K., Borazjani A., Wang R., Crow J.A., Xie S. Arch. Biochem. Biophys. 2012, 522:44-56.
26. Ross M.K., Crow J.A. J. Biochem. Mol. Toxicol. 2007, 21:187-196.
27. Sanghani S.P., Sanghani P.C., Schiel M.A., Bosron W.F. Protein Pept. Lett. 2009, 16:1207-1214.
28. Sato Y., Miyashita A., Iwatsubo T., Usui T. Drug Metab. Dispos. 2012, 40:1389-1396.
29. Satoh T., Hosokawa M. Annu. Rev. Pharmacol. Toxicol. 1998, 38:257-288.
30. Satoh T., Taylor P., Bosron W.F., Sanghani S.P., Hosokawa M., La Du B.N. Drug Metab. Dispos. 2002, 30:488-493.
31. Sekiya M., Osuga J., Nagashima S., Ohshiro T., Igarashi M., Okazaki H., Takahashi M., Tazoe F., Wada T., Ohta K., Takanashi M., Kumagai M., Nishi M., Takase S., Yahagi N., Yagyu H., Ohashi K., Nagai R., Kadowaki T., Furukawa Y., Ishibashi S. Cell Metab. 2009, 10:219-228.
32. Shi D., Yang J., Yang D., LeCluyse E.L., Black C., You L., Akhlaghi F., Yan B. J. Pharmacol. Exp. Ther. 2006, 319:1477-1484.
33. Sun Z., Murry D.J., Sanghani S.P., Davis W.I., Kedishvili N.Y., Zou Q., Hurley T.D., Bosron W.F. J. Pharmacol. Exp. Ther. 2004, 310:469-476.
34. Taketani M., Shii M., Ohura K., Ninomiya S., Imai T. Life Sci. 2007, 81:924-932.
35. Tang M., Mukundan M., Yang J., Charpentier N., LeCluyse E.L., Black C., Yang D., Shi D., Yan B. J. Pharmacol. Exp. Ther. 2006, 319:1467-1476.
36. Wang J., Williams E.T., Bourgea J., Wong Y.N., Patten C.J. Drug Metab. Dispos. 2011, 39:1329-1333.
37. Wheelock C.E., Phillips B.M., Anderson B.S., Miller J.L., Miller M.J., Hammock B.D. Rev. Environ. Contam. Toxicol. 2008, 195:117-178.
38. Xie S., Borazjani A., Hatfield M.J., Edwards C.C., Potter P.M., Ross M.K. Chem. Res. Toxicol. 2010, 23:1890-1904.
39. Xu J., Li Y., Chen W.D., Xu Y., Yin L., Ge X., Jadhav K., Adorini L., Zhang Y., Hepatic carboxylesterase 1 Is essential for both normal and farnesoid X receptor-controlled lipid homeostasis. Hepatology. http://dx.doi.org/ 10.1002/hep.26714, in press.
40. Xu Z., Xu L., Zhou J., Xu Y., Zhu W., Qian X. Chem. Commun. 2012, 48:10871-10873.
41. Yang D., Pearce R.E., Wang X., Gaedigk R., Wan Y.J., Yan B. Biochem. Pharmacol. 2009, 77:238-247.
42. Yoshimura M., Kimura T., Ishii M., Ishii K., Matsuura T., Geshi E., Hosokawa M., Muramatsu M. Biochem. Biophys. Res. Commun. 2008, 369:939-942.
43. Zhang J., Burnell J.C., Dumaual N., Bosron W.F. J. Pharmacol. Exp. Ther. 1999, 290:314-318.
44. Zhang Y., Chen W., Feng D., Shi W., Li X., Ma H. Analyst 2012, 137:716-721.
45. Zhu B., Guo B., Zhao Y., Zhang B., Du B. Biosens. Bioelectron. 2014, 55:72-75.
46. Zhu H.J., Appel D.I., Jiang Y., Markowitz J.S. Drug Metab. Dispos. 2009, 37:1819-1825.
47. Zhu H.J., Appel D.I., Johnson J.A., Chavin K.D., Markowitz J.S. Biochem. Pharmacol. 2009, 77:1266-1272.
48. Zhu H.J., Appel D.I., Peterson Y.K., Wang Z., Markowitz J.S. Toxicology 2010, 270:59-65.
49. Zhu H.J., Wang X., Gawronski B.E., Brinda B.J., Angiolillo D.J., Markowitz J.S. J. Pharmacol. Exp. Ther. 2013, 344:665-672.